Human Fas Ligand / TNFSF6 Protein, His Tag, premium grade

产品评论
货号-规格
价格
Qty.
FAL-H5241-50ug
¥4305.00
FAL-H5241-1mg (250ug X 4)
¥32550.00
Fiber-add-1piece
可选服务
询价
合计0件 产品金额¥ 0

产品信息

分子别名(Synonym)

FASLG,ALPS1B,APT1LG1,CD178,CD95L,FASL,TNFSF6

表达区间及表达系统(Source)

Human Fas Ligand, His Tag, premium grade (FAL-H5241) is expressed from human 293 cells (HEK293). It contains AA Pro 134 - Leu 281 (Accession # AAH17502.1).

Predicted N-terminus: His

It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

Request for sequence

蛋白结构(Molecular Characterization)

Fas Ligand Structure

This protein carries a polyhistidine tag at the N-terminus.

The protein has a calculated MW of 18.8 kDa. The protein migrates as 25-33 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 0.1 EU per μg by the LAL method.

无菌(Sterility)

Negative

支原体(Mycoplasma)

Negative.

纯度(Purity)

>90% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

产品数据图

 

电泳(SDS-PAGE)

Fas Ligand SDS-PAGE

Human Fas Ligand, His Tag, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

SEC-MALS

Fas Ligand SEC-MALS

The purity of Human Fas Ligand, His Tag, premium grade (Cat. No. FAL-H5241) is more than 90% and the molecular weight of this protein is around 70-88 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-ELISA

Fas Ligand ELISA

Immobilized Human Fas Ligand, His Tag, premium grade (Cat. No. FAL-H5241) at 2 μg/mL (100 μL/well) can bind Human Fas Protein, Fc Tag (MALS verified) (Cat. No. FAS-H5252) with a linear range of 0.3-5 ng/mL (QC tested).

Protocol

 

产品评论
发表评论

背景

Fas ligand is also known as FasL, CD178, CD95L, or TNFSF6, is a homotrimeric type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. Its binding with its receptor induces apoptosis. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer. Mature human Fas Ligand consists of a 179 amino acid (aa) extracellular domain (ECD), a 22 aa transmembrane segment, and a 80 aa cytoplasmic domain. Within the ECD, human Fas Ligand shares 81% and 78% aa sequence identity with mouse and rat Fas Ligand, respectively. Apoptosis triggered by Fas-Fas ligand binding plays a fundamental role in the regulation of the immune system. Its functions include:T-cell homeostasis, cytotoxic T-cell activity, immune privilege, maternal tolerance, tumor counterattack. Defective Fas-mediated apoptosis may lead to oncogenesis as well as drug resistance in existing tumors. Germline mutation of Fas is associated with autoimmune lymphoproliferative syndrome (ALPS), a childhood disorder of apoptosis.

前沿进展

 
靶点信息
  • 英文全称:

    Soluble Fas ligand

  • 中文全称:

    可溶性Fas配体

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    1 详情

  • 最高研发阶段:

    临床二期

数据表和文档
联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品信息
  • 产品数据图
  • 产品评论
  • 背景